Summary

Morgan Stanley Europe SE has filed a Form 8.5 (EPT/NON-RI) disclosure on 8 April 2026 in respect of British Land Company plc under Rule 8.5 of the UK Takeover Code. The filing discloses a neutral equity position, 3,000,000 stock-settled derivative positions (call options) on both the interest and short side, and a paired 36-share purchase and sale on 7 April 2026.

Introduction

Morgan Stanley Europe SE, acting as an exempt principal trader without recognised intermediary status, released a Form 8.5 (EPT/NON-RI) disclosure on 8 April 2026 at 07:49 BST via the London Stock Exchange. The filing relates to its dealings and positions in British Land Company plc 25p ordinary shares and is made under Rule 8.5 of the UK City Code on Takeovers and Mergers.

Form 8.5 is one of the most widely used tools in the UK Takeover Code’s disclosure toolkit. It applies to exempt principal traders connected with a party to an offer, and requires near-real-time reporting of their positions and dealings. Because exempt principal traders are typically investment banks running market-making and client-facing books, their filings are a rich source of information on day-to-day market microstructure during a takeover situation.

This article explains what the disclosure contains, why Morgan Stanley Europe SE is classified as EPT/NON-RI, how the disclosed positions should be interpreted and what the filing means for investors tracking British Land and the wider FTSE 100 REIT landscape.

Detailed Explanation of the Announcement

What is a Form 8.5 (EPT/NON-RI)?

Form 8.5 is the public disclosure template used by exempt principal traders under Rule 8.5 of the UK Takeover Code. Exempt principal traders are dealers affiliated with a connected party to an offer and are formally recognised by the UK Takeover Panel as such. The “NON-RI” designation means the filer either does not have, or is not acting in its capacity as, a Recognised Intermediary for the purposes of the Code. The separate “EPT/RI” form is used when the dealer is acting in a client-serving capacity with Recognised Intermediary status.

The requirement to file an EPT/NON-RI disclosure is triggered when a connected exempt principal trader holds, deals in or writes derivatives over a class of relevant securities of an offeror or offeree during the offer period. The form requires disclosure of opening positions, cash-settled derivative positions, stock-settled derivative positions and subsequent dealings.

Morgan Stanley Europe SE as Filer

The filer is Morgan Stanley Europe SE, the European investment banking entity of the Morgan Stanley group. It has filed the form in its capacity as an exempt principal trader connected with British Land Company plc, the offeree. The form also indicates that Morgan Stanley Europe SE is making disclosures in respect of another party to the offer, namely Life Science REIT plc. This is consistent with British Land being in an offer period in which Life Science REIT plc is also involved.

The Positions Disclosed

The form sets out positions in the 25p ordinary shares of British Land Company plc. Direct holdings of relevant securities are reported at zero on both the interest and short-position side, as are cash-settled derivative exposures. However, the stock-settled derivative row shows a position of 3,000,000 shares on both the interest side and the short position side, each at 0.3%. This is consistent with Morgan Stanley Europe SE running a matched long and short derivative exposure.

A Supplemental Form 8 (Open Positions) has been attached to the filing. It discloses a pair of 3,000,000-share call options: one call option written at an exercise price of 0.2050 GBP, and one call option purchased at the same exercise price of 0.2050 GBP. Both are European-style options with an expiry date of 17 December 2027. The effect is a neutral structural exposure — the written and purchased calls effectively offset at the notional level, but must still be disclosed under Takeover Code rules because they relate to the relevant securities of the offeree.

Key Financial and Operational Details

Filing Fundamentals

  • Discloser: Morgan Stanley Europe SE
  • Role: Exempt Principal Trader, NON-RI
  • Offeree: British Land Company plc, The
  • Connected party to the offer: British Land Company plc, The
  • Additional offeree/offeror covered: Life Science REIT plc
  • Position date: 7 April 2026
  • Date of disclosure: 8 April 2026
  • Relevant security class: 25p ordinary shares
  • Supplemental Form 8 (Open Positions) attached: Yes

Interests and Short Positions

  • Relevant securities owned and/or controlled: 0
  • Cash-settled derivatives: 0
  • Stock-settled derivatives (including options) — interests: 3,000,000 shares (0.3%)
  • Stock-settled derivatives (including options) — short positions: 3,000,000 shares (0.3%)
  • Total interests: 3,000,000 (0.3%)
  • Total short positions: 3,000,000 (0.3%)

Dealings on 7 April 2026

  • Purchases: 36 shares of 25p ordinary at 3.6560 GBP (highest and lowest)
  • Sales: 36 shares of 25p ordinary at 3.6560 GBP (highest and lowest)
  • Cash-settled derivative transactions: N/A
  • Other dealings: None disclosed

Supplemental Form 8 — Open Derivative Positions

  • 25p ordinary: CALL WRITTEN 3,000,000, exercise price 0.2050 GBP, European style, expiry 17 December 2027
  • 25p ordinary: CALL PURCHASED 3,000,000, exercise price 0.2050 GBP, European style, expiry 17 December 2027
  • Agreements to purchase or sell (Section 3): None

Why This Announcement Matters

Form 8.5 (EPT/NON-RI) disclosures are an integral component of the UK’s takeover transparency architecture. They provide public visibility into the proprietary and market-making books of investment banks connected to parties in an offer. Even where net positions are small or matched, the existence and scale of gross positions can materially affect market liquidity, hedging flow and implied demand for the relevant securities during the offer period.

The headline from this filing is that Morgan Stanley Europe SE has a 3,000,000-share stock-settled derivative position on both the long and short side of British Land 25p ordinary shares. On a net basis this is a flat exposure, but from a hedging and flow perspective it is not inert: structural option positions are typically managed dynamically as the underlying price and volatility change, which can generate trading flow that is visible to other market participants. The filing also reveals that the positions run to an expiry date of 17 December 2027, giving them a long-dated horizon.

The pairing of a 36-share purchase and a 36-share sale at identical prices on 7 April 2026 is small in absolute terms, but it is consistent with minor housekeeping trades or client-facing activity that must be disclosed when Morgan Stanley Europe SE is classified as a connected exempt principal trader. The mere existence of these trades at such a low volume highlights how finely grained the UK Takeover Code’s disclosure obligations can be.

Business and Market Context

British Land and the UK REIT Sector

British Land Company plc is a FTSE 100 real estate investment trust focused on high-quality UK commercial property assets. The company owns and manages an established portfolio of offices, retail, mixed-use campuses and urban regeneration developments. Its inclusion in this Form 8.5 filing highlights that it is currently a party to an offer under the UK Takeover Code.

The UK REIT sector has experienced elevated corporate activity in recent years, driven by persistent NAV discounts, funding cost pressures and a search for scale. Investors watching the British Land situation should therefore read the Morgan Stanley Europe SE disclosure alongside other Form 8 filings that may involve other party banks, sovereign holders, index funds and event-driven investors.

Life Science REIT plc as an Additional Disclosure Target

The filing also discloses that Morgan Stanley Europe SE is making disclosures in respect of Life Science REIT plc as an additional party to the offer. This suggests that Life Science REIT plc is linked to the same transaction structure as British Land for Takeover Code disclosure purposes. Investors should watch for parallel Form 8 disclosures relating to Life Science REIT plc to understand the full shape of the offer.

Exempt Principal Trader Status Explained

Under the UK Takeover Code, certain investment banks can apply for Exempt Principal Trader status through the Panel. This recognises the fact that such entities run proprietary and market-making books that may trade in the securities of offerors and offerees for genuine liquidity reasons, not in support of a connected corporate advisory client. The exemption allows them to continue trading during an offer period, subject to the public disclosure of their positions and dealings via Form 8.5.

The “NON-RI” designation is simply a formal recognition that the filer is not acting in a client-serving capacity where the Recognised Intermediary status under the Code would apply. In contrast, the “EPT/RI” form is filed where Recognised Intermediary status is relevant to the trader’s dealings.

Implications for Investors

For Event-Driven and Arbitrage Funds

Event-driven funds watching the offer involving British Land and Life Science REIT plc will treat this Form 8.5 as a data point in their ownership and flow analysis. The 3,000,000-share matched stock-settled derivative position represents ongoing hedging activity that could influence trading flow, especially around option expiries and corporate event dates.

For Market Microstructure Analysts

Analysts studying market microstructure will note the precise paired 36-share purchase and sale at 3.6560 GBP on 7 April 2026. While numerically trivial, this is the kind of housekeeping trade that must be disclosed under Rule 8.5 and reveals how granular the transparency regime is during an active offer period. It also highlights the compliance infrastructure required by investment banks to produce these filings on a daily basis.

For Long-Only Investors

Long-only investors generally do not need to react to Form 8.5 filings in isolation, because they document the activity of connected exempt principal traders rather than directional views on the stock. However, consistent filings over time can provide an indirect indication of how much of the market liquidity in an offeree’s shares is being absorbed by hedging and market-making activity connected to the offer.

Risks, Caveats, and Uncertainty Factors

The positions disclosed in Form 8.5 can change rapidly. Investors should not treat a single filing as a definitive picture of Morgan Stanley Europe SE’s exposure to British Land, because subsequent filings may reveal material changes in positions as the offer period progresses.

The identity of the offeror in this situation and the specific commercial terms of the offer are not revealed by the Form 8.5 itself; that information is contained in the offeror’s formal offer document and subsequent regulatory announcements. Any investment decision should be informed by those primary documents rather than by a Rule 8.5 disclosure alone.

Option positions carry their own risks, including delta exposure, gamma sensitivity, time decay and implied volatility shifts. While the matched nature of the calls disclosed here suggests a hedged structure, investors should understand that dynamic hedging can generate flow that temporarily influences price formation in the underlying stock.

Short-Term and Long-Term Outlook

Short-Term Outlook

In the short term, Morgan Stanley Europe SE is expected to continue filing Form 8.5 (EPT/NON-RI) disclosures for British Land and any other parties to the offer on a daily basis during the offer period. Each of these filings will provide a running commentary on its matched book, hedging activity and any new stock-settled derivative positions.

Market participants should monitor the parallel flow of Form 8.3 filings from large institutional holders and Form 8.5 (EPT/RI) filings from client-serving trading desks to build a comprehensive picture of ownership and activity in British Land 25p ordinary shares.

Long-Term Outlook

Over the longer term, the resolution of the offer period for British Land and Life Science REIT plc will determine whether stock-settled derivative positions such as the ones disclosed by Morgan Stanley Europe SE are exercised, offset or allowed to expire. The options disclosed in the Supplemental Form 8 run until 17 December 2027, indicating that market-makers and dealers are structuring positions with a multi-year horizon.

More broadly, ongoing M&A activity in the UK listed real estate sector is likely to continue as long as NAV discounts, financing costs and strategic rationale for scale support opportunistic transactions. Exempt principal traders will remain a key source of liquidity throughout these processes, subject to the Takeover Code’s transparency regime.

Further Context and Analysis

Reading Matched Derivative Books

Matched derivative books, in which a dealer simultaneously writes and purchases equivalent option notionals at the same strike and expiry, are a common feature of sell-side trading operations. They often arise from market-making activity in listed or bilateral options, from the unwinding of client trades, or from internal transfers between desks. In the context of a Takeover Code filing, the key point is that both legs must be disclosed separately as gross positions, even though the net economic exposure is close to zero.

This form of disclosure can sometimes create the impression that a dealer holds a large directional position when, in reality, the trading book is largely hedged. Reading Form 8.5 (EPT/NON-RI) filings carefully therefore requires attention to both the long and short sides of stock-settled derivative rows, the size of the interest and short totals, and any Supplemental Form 8 annexes describing the precise option terms.

Transparency and Liquidity in UK Large Caps

One of the defining features of the London market is its depth of disclosure around corporate events. The combination of Form 8.3 and Form 8.5 filings provides investors with a near-real-time view of the shareholder register during an offer period, across substantial shareholders, connected traders and client-serving dealers. For stocks such as British Land that sit in the FTSE 100 with large free floats, that transparency is particularly valuable.

Investors comparing successive Form 8.5 filings from different exempt principal traders can often identify where the bulk of hedging and market-making activity is concentrated, and use that information to calibrate their own liquidity assumptions and execution strategies. In this sense, the Morgan Stanley Europe SE filing is a single contribution to a larger mosaic of public information.

Conclusion

The 8 April 2026 Form 8.5 (EPT/NON-RI) filing by Morgan Stanley Europe SE provides useful transparency on the bank’s connected exempt principal trader activity in British Land Company plc during an active offer period. The filing reveals a matched 3,000,000-share stock-settled derivative book, two call options on the 25p ordinary shares expiring in December 2027 and a paired 36-share equity trade on 7 April 2026.

For FTSE 100 investors, REIT analysts and event-driven professionals, this kind of disclosure is a reminder of the depth of the UK Takeover Code’s transparency regime and the role that investment banks play in providing liquidity around corporate events. While the net exposure is small and hedged, the filing offers a valuable data point for anyone building a holistic view of the British Land situation.

Key Takeaways for Investors

  • Morgan Stanley Europe SE has filed a Form 8.5 (EPT/NON-RI) on British Land Company plc dated 8 April 2026
  • Direct equity and cash-settled derivative exposure is reported at zero on both the long and short side
  • Stock-settled derivatives show a matched 3,000,000-share position at 0.3% on each side, fully hedged at the notional level
  • The Supplemental Form 8 reveals European-style call options written and purchased at 0.2050 GBP expiring 17 December 2027
  • Only 36 shares were bought and 36 shares sold at 3.6560 GBP on 7 April 2026, highlighting the granularity of Rule 8.5 disclosures
  • Life Science REIT plc is also disclosed as a related party to the offer, suggesting a linked transaction structure
  • Investors should interpret the filing as transparency around connected trading activity rather than a directional view

Disclaimer

This content is for informational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security.